Disclosures for "Long-term Clinical Outcome of Cryptogenic New-onset Refractory Status Epilepticus (C-NORSE) Patients"
-
Mr. Jang has nothing to disclose.
-
Dr. Ahn has nothing to disclose.
-
Miss Mon has nothing to disclose.
-
Ms. YOU has nothing to disclose.
-
Prof. Park has nothing to disclose.
-
Han Sang Lee has nothing to disclose.
-
Prof. Chu has nothing to disclose.
-
Prof. Lee has nothing to disclose.
-
Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celltrion. The institution of Prof. Lee has received research support from Roche. The institution of Prof. Lee has received research support from Autoimmune Encephalitis Alliance. The institution of Prof. Lee has received research support from Celltrion. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care.